We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

204 hedge funds and large institutions have $3.47B invested in IDEAYA Biosciences in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 78 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 12

132% more call options, than puts

Call options by funds: $1.4M | Put options by funds: $601K

50% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 52

45% more capital invested

Capital invested by funds: $2.4B → $3.47B (+$1.07B)

30% more funds holding

Funds holding: 157 → 204 (+47)

1.53% more ownership

Funds ownership: 104.51% → 106.05% (+1.5%)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

Holders
204
Holders Change
+47
Holders Change %
+29.94%
% of All Funds
2.94%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
59
Increased
78
Reduced
52
Closed
12
Calls
$1.4M
Puts
$601K
Net Calls
+$794K
Net Calls Change
+$505K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$398M
2
Fiera Capital (Canada)
Fiera Capital (Canada)
Quebec, Canada
+$46.8M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$41.8M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$29.2M
5
BlackRock
BlackRock
New York
+$22.7M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$73.2M
2
APM
Avidity Partners Management
Texas
-$31M
3
SI
Sofinnova Investments
California
-$29.1M
4
BI
BVF Inc
California
-$24.4M
5
PIM
Platinum Investment Management
Australia
-$21.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Axa
51
Axa
France
$10.7M +$2.92K +68 +0%
UBS Group
52
UBS Group
Switzerland
$10.7M +$3.97M +92,347 +61%
UBS AM
53
UBS AM
Illinois
$10.2M -$1.83M -42,583 -16%
Bank of New York Mellon
54
Bank of New York Mellon
New York
$9.71M +$202K +4,696 +2%
SCM
55
Superstring Capital Management
New York
$9.53M -$1.47M -34,225 -14%
Ameriprise
56
Ameriprise
Minnesota
$9.37M -$457K -10,627 -5%
Citigroup
57
Citigroup
New York
$9M +$4.96M +115,418 +129%
Rafferty Asset Management
58
Rafferty Asset Management
New York
$8.83M +$341K +7,935 +4%
VOYA Investment Management
59
VOYA Investment Management
Georgia
$7.98M -$1.64M -38,038 -17%
TD Asset Management
60
TD Asset Management
Ontario, Canada
$7.98M +$1.9M +44,200 +32%
Wellington Management Group
61
Wellington Management Group
Massachusetts
$7.61M +$3.84M +89,405 +106%
PIM
62
Platinum Investment Management
Australia
$7.13M -$21.5M -499,789 -75%
NIP
63
Nicholas Investment Partners
California
$6.84M +$1.96M +45,469 +41%
Millennium Management
64
Millennium Management
New York
$6.06M +$5.94M +138,211 New
Wells Fargo
65
Wells Fargo
California
$5.5M +$4.65M +108,031 +627%
Hudson Bay Capital Management
66
Hudson Bay Capital Management
Connecticut
$5.44M +$1.69M +39,400 +47%
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
$5.4M -$3.64M -84,720 -41%
Walleye Capital
68
Walleye Capital
New York
$5M -$3.69M -85,854 -43%
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.91M +$838K +19,483 +21%
Swiss National Bank
70
Swiss National Bank
Switzerland
$4.89M +$1.13M +26,300 +31%
Marshall Wace
71
Marshall Wace
United Kingdom
$4.84M +$4.74M +110,351 New
HS
72
HighVista Strategies
Massachusetts
$4.36M -$1.18M -27,553 -22%
TC
73
TwinBeech Capital
New York
$4.27M +$4.19M +97,422 New
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$4.23M +$449K +10,444 +12%
JP Morgan Chase
75
JP Morgan Chase
New York
$4.08M -$1.01M -23,528 -20%
1 2
3
4 5

IDYA Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2024, worth a combined $3.47B — up 45% from $2.4B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new IDYA positions and 12 closed out — a net gain of 47 holders — while 78 added to existing stakes and 52 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $398M. The largest seller was Morgan Stanley, cutting an estimated $73.2M.

  • 204 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2024, up from 157 in Q4 2023.
  • Funds reported $3.47B of IDEAYA Biosciences stock for Q1 2024, up 45% quarter-over-quarter.
  • 59 funds opened new IDEAYA Biosciences positions in Q1 2024 and 12 closed out, a net change of +47 holders.
  • The largest IDEAYA Biosciences buyer in Q1 2024 was Fidelity Investments, an estimated $398M added.
  • The largest IDEAYA Biosciences seller in Q1 2024 was Morgan Stanley, an estimated $73.2M sold.

Based on aggregated 13F filings for Q1 2024.